As a healthcare company committed to therapeutic progress to serve patient needs, Servier works for and with patients at every stage of the medicine life cycle. This commitment has been rewarded by the Group’s significant progress in the rankings of PatientView’s 2021 survey of patient organizations around the world.
Servier was ranked 26th (+5 places) out of a total of 45 in the survey of the reputation of pharmaceutical companies by patient organizations working with the Group. Servier is also ranked 28th (+7 places) among patient organizations that are familiar with the Group.
Among patient associations that have worked with Servier in the field of oncology, the Group moved up one place from 2020 to 7th place out of a total of 30.
Servier is, moreover, among the laboratories that have made the most progress in the ranking, the organization notes in its press release.
“We are very grateful for the appreciation shown by patient organizations. It illustrates our ongoing commitment to integrate the voice of the patient in all our projects in cooperation with patient organizations,” said Bertrand Renaud, Chief Patient Officer.